chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity, Vaccination site pain
Clinical narrative: LUE pain; bone pain; mialgia/muscle aches; all over joint pain; fatigue; chills; sore Left deltoid; body aches/all over body aches; Headache; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EK5730), intramuscular on 19Dec2020 07:00 am at single dose at left arm for covid-19 immunization. Medical history included hypertension, covid-19 (prior vaccination). No known allergies. Concomitant medications in two weeks included amlodipine besilate (NORVASC), ascorbic acid (VIT C), ergocalciferol (VIT D), magnesium chloride (MAG), zinc and daily multivitamins. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, patient had not been tested for COVID-19. The patient experienced sore left deltoid, body aches, headache all on 19Dec2020 16:00, all over body aches, headache, fatigue and chills all on 20Dec2020, mialgia/muscle aches, fatigue, headache and all over joint pain all on 21Dec2020, headache, LUE pain, muscle and bone pain, fatigue all on 22Dec2020, patient finally felt better with decreased symptoms on 23Dec2020. Outcome of all events was recovered on unspecified date. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care. Patient received paracetamol (TYLENOL), motrin for events.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Nausea, Pain, Pyrexia
Clinical narrative: Nausea; Vomiting; Body aches; Chills; Low grade fever 99.8; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported for herself that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunization. The patient medical and concomitant medications were not reported.  The patient experienced nausea, vomiting, body aches, chills, and low grade fever 99.8 on 08Jan2021. She stated that she has been afebrile for 24 hours. She was scheduled to receive the second dose on 10Jan2021. She did have a PCR send off test for COVID-19 but had not yet received the results. She stated that she did not think she has COVID-19 but she was not sure. She was wondering if she should still get the second dose of the vaccine on 10Jan2021. The outcome of fever was recovered in Jan2021, of the other events was unknown. She stated that her institution was telling her if she delay getting her second dose of the COVID-19 vaccine then she would need to restart the vaccination series. She would like to know if this information was accurate.  Information on the batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vomiting
Clinical narrative: Nausea; Vomiting; Body aches; Chills; Low grade fever 99.8; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported for herself that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunization. The patient medical and concomitant medications were not reported.  The patient experienced nausea, vomiting, body aches, chills, and low grade fever 99.8 on 08Jan2021. She stated that she has been afebrile for 24 hours. She was scheduled to receive the second dose on 10Jan2021. She did have a PCR send off test for COVID-19 but had not yet received the results. She stated that she did not think she has COVID-19 but she was not sure. She was wondering if she should still get the second dose of the vaccine on 10Jan2021. The outcome of fever was recovered in Jan2021, of the other events was unknown. She stated that her institution was telling her if she delay getting her second dose of the COVID-19 vaccine then she would need to restart the vaccination series. She would like to know if this information was accurate.  Information on the batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Oropharyngeal pain, Rhinorrhoea, Vaccination site pain
Clinical narrative: Soar throat; Chills; Tired; Runny nose/ Felt like nose flu; Arm sore; This is a spontaneous report from a contactable Nurse. A female patient of an unspecified age (Age: 27; Unit: Unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced arm sore on 04Jan2021, soar throat on 07Jan2021, chills on 07Jan2021, tired on 07Jan2021, runny nose/ felt like nose flu on 07Jan2021 Outcome of events was unknown.    Information on the lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Fever/body ache on day 4; Fever/body ache on day 4; Headache on day 2 and 3; This is a spontaneous report from a non-contactable consumer (patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686) via an unspecified route of administration at left arm on 06Jan2021 14:45 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced headache on day 2 (reported as 08Jan2021) and 3, fever/body ache on day 4 (10Jan2021). Patient received Ibuprofen as treatment for the events. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was not recovered.   No follow up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Malaise, Vaccination site pain
Clinical narrative: moderate diarrhea; incredible soreness to injection site (left deltoid); general malaise tiredness within 2 hours of administration; general malaise tiredness within 2 hours of administration; This is a spontaneous report from a non-contactable nurse reporting for herself. A 38-year-old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL0142, expiry date not reported) on 06Jan2021 intramuscularly in the left arm  for COVID-19 immunization. There was no relevant medical history and no concomitant medications. The patient had not had COVID prior to the vaccination and she was not tested post the vaccination. On 06Jan2021, the patient experienced general malaise tiredness within 2 hours of administration. On 07Jan2021, she experienced severe soreness (stated as "incredible soreness") to injection site (left deltoid). On 08Jan2021, she experienced moderate diarrhea (per CDC systemic reaction classification). The events were non-serious. No treatment received for the events. The events were resolved on an unspecified date in Jan2021.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Decreased appetite, Fatigue
Clinical narrative: Throbbing pain; tingling fingers in left arm; pain going up the neck of left side; fever; chills; joint pain (both shoulders, low back, hips, and knee); loss of appetite; fatigue; weakness; headache; muscle pain; This is a spontaneous report from a contactable Other HCP (patient). This 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 08Jan2021 on Arm left at single dose (Lot # 3249) for covid-19 immunisation. Medical history included Osteoporosis, vitamin D deficient. No known allergies. No other vaccine in four weeks. Concomitant medications included other medications in two weeks. She experienced throbbing pain and tingling fingers in left arm, pain going up the neck of left side. Also experience typical side effects: fever, chills, joint pain (both shoulders, low back, hips, and knee), loss of appetite, fatigue, weakness, headache, and muscle pain on 09Jan2021. No Covid prior vaccination. No covid tested post vaccination. No treatments received. Outcome of the events was recovering.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Neck pain, Pain, Paraesthesia
Clinical narrative: Throbbing pain; tingling fingers in left arm; pain going up the neck of left side; fever; chills; joint pain (both shoulders, low back, hips, and knee); loss of appetite; fatigue; weakness; headache; muscle pain; This is a spontaneous report from a contactable Other HCP (patient). This 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 08Jan2021 on Arm left at single dose (Lot # 3249) for covid-19 immunisation. Medical history included Osteoporosis, vitamin D deficient. No known allergies. No other vaccine in four weeks. Concomitant medications included other medications in two weeks. She experienced throbbing pain and tingling fingers in left arm, pain going up the neck of left side. Also experience typical side effects: fever, chills, joint pain (both shoulders, low back, hips, and knee), loss of appetite, fatigue, weakness, headache, and muscle pain on 09Jan2021. No Covid prior vaccination. No covid tested post vaccination. No treatments received. Outcome of the events was recovering.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Throbbing pain; tingling fingers in left arm; pain going up the neck of left side; fever; chills; joint pain (both shoulders, low back, hips, and knee); loss of appetite; fatigue; weakness; headache; muscle pain; This is a spontaneous report from a contactable Other HCP (patient). This 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 08Jan2021 on Arm left at single dose (Lot # 3249) for covid-19 immunisation. Medical history included Osteoporosis, vitamin D deficient. No known allergies. No other vaccine in four weeks. Concomitant medications included other medications in two weeks. She experienced throbbing pain and tingling fingers in left arm, pain going up the neck of left side. Also experience typical side effects: fever, chills, joint pain (both shoulders, low back, hips, and knee), loss of appetite, fatigue, weakness, headache, and muscle pain on 09Jan2021. No Covid prior vaccination. No covid tested post vaccination. No treatments received. Outcome of the events was recovering.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling abnormal, Pain, Pain in extremity
Clinical narrative: Dizziness; brain fog; achy; chills; sore arm; This is a spontaneous report from a contactable other HCP(patient). A 48-year-old female patient received first dose BNT162B2, via an unspecified route of administration at Arm Right on 30Dec2020 10:00 at the 48 years old at single dose for COVID-19 immunization. The medical history included Rheumatoid arthritis and Depression. The concomitant medications were hydroxychloroquine phosphate ( PLAQUENIL ), leflunomide(ARAVA), desvenlafaxine succinate(PRISTIQ). The patient previously took Methotrexate and experienced allergies. On 31Dec2020 11:00, the patient experienced Dizziness, brain fog, achy, chills, sore arm. Mild for maybe 6 hours and a couple hours were moderate. Woke the next day on 01Jan2021 feeling fabulous. There was no treatment received for all the adverse events. There was covid tested post vaccination. There was no other vaccine in four weeks. The patient underwent lab tests and procedures, which included Nasal Swab on 30Oct2020 Negative. The outcome of the events was recovered on 01Jan2021.  Information about lot/batch number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Dizziness; brain fog; achy; chills; sore arm; This is a spontaneous report from a contactable other HCP(patient). A 48-year-old female patient received first dose BNT162B2, via an unspecified route of administration at Arm Right on 30Dec2020 10:00 at the 48 years old at single dose for COVID-19 immunization. The medical history included Rheumatoid arthritis and Depression. The concomitant medications were hydroxychloroquine phosphate ( PLAQUENIL ), leflunomide(ARAVA), desvenlafaxine succinate(PRISTIQ). The patient previously took Methotrexate and experienced allergies. On 31Dec2020 11:00, the patient experienced Dizziness, brain fog, achy, chills, sore arm. Mild for maybe 6 hours and a couple hours were moderate. Woke the next day on 01Jan2021 feeling fabulous. There was no treatment received for all the adverse events. There was covid tested post vaccination. There was no other vaccine in four weeks. The patient underwent lab tests and procedures, which included Nasal Swab on 30Oct2020 Negative. The outcome of the events was recovered on 01Jan2021.  Information about lot/batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Body temperature fluctuation, Chills, Dizziness
Clinical narrative: fatigue; malaise; severe headache; chills; myalgia; arthralgia; temperature fluctuations; lightheaded ness; diaphoresis; This is a spontaneous report from a contactable Healthcare Professional reporting for herself. A 34-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, on 17Dec2020 at 17:00 (Lot # EK5730) via intramuscular route in right arm and the second dose on 07Jan2021 at 17:30 (Lot # EK9231), at 34 years of age, via intramuscular route in left arm, both at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination and had no relevant medical history and no known allergies. She was vaccinated in hospital. Concomitant medication included sertraline hydrochloride (ZOLOFT), cetirizine hydrochloride (ZYRTEC) and mometasone furoate (FLONASE). On 08Jan2021 at 16:00 the patient experienced fatigue, malaise, severe headache, chills, myalgia, arthralgia, temperature fluctuations, lightheadedness and diaphoresis. No treatment was received for the reported events. At the time of the report the reported events had not resolved yet. The patient commented that these events may still be considered normal, but she still had been experiencing them 3 days post vaccine, they have persisted long enough and she thought she should report them.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Malaise, Myalgia
Clinical narrative: fatigue; malaise; severe headache; chills; myalgia; arthralgia; temperature fluctuations; lightheaded ness; diaphoresis; This is a spontaneous report from a contactable Healthcare Professional reporting for herself. A 34-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, on 17Dec2020 at 17:00 (Lot # EK5730) via intramuscular route in right arm and the second dose on 07Jan2021 at 17:30 (Lot # EK9231), at 34 years of age, via intramuscular route in left arm, both at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination and had no relevant medical history and no known allergies. She was vaccinated in hospital. Concomitant medication included sertraline hydrochloride (ZOLOFT), cetirizine hydrochloride (ZYRTEC) and mometasone furoate (FLONASE). On 08Jan2021 at 16:00 the patient experienced fatigue, malaise, severe headache, chills, myalgia, arthralgia, temperature fluctuations, lightheadedness and diaphoresis. No treatment was received for the reported events. At the time of the report the reported events had not resolved yet. The patient commented that these events may still be considered normal, but she still had been experiencing them 3 days post vaccine, they have persisted long enough and she thought she should report them.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Confusional state, Diarrhoea, Dyspepsia, Fatigue
Clinical narrative: Got acute pain in my stomach/stomach pain; Diarrhea; Passed undigested food; Fatigue; A little confusion; Muscle pain at the site of injection; The site was also hot and swollen for at least 12 hours; The site was also hot and swollen for at least 12 hours; This is a spontaneous report from a contactable Other HCP. This 37-year-old female Other HCP (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK3730, Expedite date:Mar2021 ) at single dose for COVID-19 immunization on 31Dec2020, 10:30 AM.  Relevant history was unknown. Relevant concomitant drugs included citalopram 40mg daily, alprazolam 0.5 mg as needed. About 3-4 hours after injection, the patient got acute pain in her stomach. She had diarrhea and stomach pain for 5 days. She passed undigested food for about 3 days. Day of injection she had fatigue, a little confusion, and muscle pain at the site of injection. The site was also hot and swollen for at least 12 hours. No treatment was received. The outcome of events was resolved. The patient had not COVID prior vaccination. The patient had not have COVID tested post vaccination.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Got acute pain in my stomach/stomach pain; Diarrhea; Passed undigested food; Fatigue; A little confusion; Muscle pain at the site of injection; The site was also hot and swollen for at least 12 hours; The site was also hot and swollen for at least 12 hours; This is a spontaneous report from a contactable Other HCP. This 37-year-old female Other HCP (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK3730, Expedite date:Mar2021 ) at single dose for COVID-19 immunization on 31Dec2020, 10:30 AM.  Relevant history was unknown. Relevant concomitant drugs included citalopram 40mg daily, alprazolam 0.5 mg as needed. About 3-4 hours after injection, the patient got acute pain in her stomach. She had diarrhea and stomach pain for 5 days. She passed undigested food for about 3 days. Day of injection she had fatigue, a little confusion, and muscle pain at the site of injection. The site was also hot and swollen for at least 12 hours. No treatment was received. The outcome of events was resolved. The patient had not COVID prior vaccination. The patient had not have COVID tested post vaccination.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Inappropriate schedule of product administration, Migraine
Clinical narrative: fever; pulsating migraine; joint and muscle aches and pains; joint and muscle aches and pains; dizziness; fatigue; First dose on 21Dec2020, second dose on 06Jan2021; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself.  A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular at Left arm on 06Jan2021 15:15 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included swine flu. Concomitant medications included buspirone, venlafaxine, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL XR), ethinylestradiol, levonorgestrel (AVIANE) for birth control, plantago ovata fibre (FIBER SUPPLEMENT), probiotics and women's multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's historic vaccine included first dose of BNT162B2 (lot number: EL0140), Intramuscular at left arm on 21Dec2020 15:15 for covid-19 immunization. On 07Jan2021 11:00, the patient experienced fever, pulsating migraine, joint and muscle aches and pains, dizziness, fatigue - absolutely could not have went to work if she was scheduled that day - just moving from her left side onto her right side took immense effort and tears - haven't experienced anything like it since she had swine flu. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events fever, pulsating migraine, 'joint and muscle aches and pains', dizziness, fatigue was recovered on an unknown date in Jan2021.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: fever; pulsating migraine; joint and muscle aches and pains; joint and muscle aches and pains; dizziness; fatigue; First dose on 21Dec2020, second dose on 06Jan2021; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself.  A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular at Left arm on 06Jan2021 15:15 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included swine flu. Concomitant medications included buspirone, venlafaxine, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL XR), ethinylestradiol, levonorgestrel (AVIANE) for birth control, plantago ovata fibre (FIBER SUPPLEMENT), probiotics and women's multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's historic vaccine included first dose of BNT162B2 (lot number: EL0140), Intramuscular at left arm on 21Dec2020 15:15 for covid-19 immunization. On 07Jan2021 11:00, the patient experienced fever, pulsating migraine, joint and muscle aches and pains, dizziness, fatigue - absolutely could not have went to work if she was scheduled that day - just moving from her left side onto her right side took immense effort and tears - haven't experienced anything like it since she had swine flu. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events fever, pulsating migraine, 'joint and muscle aches and pains', dizziness, fatigue was recovered on an unknown date in Jan2021.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pyrexia
Clinical narrative: fever/Fever for 36 hours after getting the vaccine; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, assuming lot was EK9231), via an unspecified route of administration on 08Jan2021 at single dose for covid-19 immunisation.  Medical history was none. The patient's concomitant medications were not reported. Patient experienced fever for 36 hours after getting the vaccine. Patient was just wondering if she should be concerned about lasting dizziness. It's been about 56 hours since she had the injection. Therapeutic measures were taken as a result of the events included paracetamol (TYLENOL), 500 mg. Patient reported the due date for the second dose would be 29Jan2021. Outcome of the events was unknown.  Information on lot/batch number has been requested.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: chills; fever; body ache; swollen lymph glands; This is a spontaneous report from a contactable Other-Hcp (patient). This 31-year-old female patient received the second dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH, lot number=Ek9231), via an unspecified route of administration on 08Jan2021 at 04:45 PM at single dose on left arm for COVID-19 immunisation. No medical history and no known allergies. Concomitant medication included ethinylestradiol / etonogestrel (NUVARING). The patient did not have other-vaccine-in-four weeks. The patient did not have COVID-prior-vaccination. The patient did not have COVID tested post vaccination. The patient previously received the first dose of BNT162B2 (lot number=Ek5730), via an unspecified route of administration on 18Dec2020 at 10:45 AM on left arm for COVID-19 immunisation. The patient experienced chills, fever, body ache and swollen lymph glands on 08Jan2021 at 11:45 PM with outcome of recovered in Jan2021. No treatment received for the events.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Nausea, Sinus congestion
Clinical narrative: severe joint aches/ milder joint pain; I also have had nausea without vomiting.; I have also had sinus congestion without drainage; on 17Dec2020 02:30 PM/ second dose of BNT162B2 on 07Jan2021 08:15; This is a spontaneous report from a contactable other health professional (patient). A 28-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19), via an unspecified route of administration at right arm on 07Jan2021 08:15 at single dose for COVID-19 immunization. Medical history included chronic migraine and no known allergies. The historical vaccine included the first dose of BNT162B2 on 17Dec2020 02:30 PM at right arm for COVID-19 immunization and no notable adverse effects. Concomitant medication included ibuprofen; acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE) and Vitafusion men's in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After the second dose, the patient have experienced severe joint aches the first night, and milder joint pain since. The patient also had had nausea without vomiting. I had also had sinus congestion without drainage, all after the second round. The events onset date was 08Jan2021 01:30. No treatment received for the adverse events.  The events outcome was recovering. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Influenza, Myalgia, Nausea
Clinical narrative: Fatigue; arm pain at shot site; muscle aches; nausea; fever; basic flu symptoms; This is a spontaneous report from a non-contactable other HCP (Patient). A 51-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration at left arm on 08Jan2021 09:30 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital.  Medical history included asthma, covid-19 prior vaccination. The patient's concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 18Dec2020 09:30 at single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Jan2021 at time of 06:30 PM, the patient experienced fatigue, arm pain at shot site, muscle aches, nausea, fever, basic flu symptoms. No treatment received for the events. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered in Jan2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Fatigue; arm pain at shot site; muscle aches; nausea; fever; basic flu symptoms; This is a spontaneous report from a non-contactable other HCP (Patient). A 51-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration at left arm on 08Jan2021 09:30 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital.  Medical history included asthma, covid-19 prior vaccination. The patient's concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 18Dec2020 09:30 at single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Jan2021 at time of 06:30 PM, the patient experienced fatigue, arm pain at shot site, muscle aches, nausea, fever, basic flu symptoms. No treatment received for the events. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered in Jan2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vaccination site mass, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: A lot of pain in arm; arm was completely swollen with hard ball underneath where the injection was given. It's extremely hot and it's extremely itchy; arm was completely swollen with hard ball underneath where the injection was given. It's extremely hot and it's extremely itchy; arm was completely swollen with hard ball underneath where the injection was given. It's extremely hot and it's extremely itchy; arm was completely swollen with hard ball underneath where the injection was given. It's extremely hot and it's extremely itchy; This is a spontaneous report from a contactable other hcp (patient).  A 49-years-old female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3246), via an unspecified route of administration on 08Jan2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose bnt162b2 on 18Dec2020 for Covid-19 Immunization and experienced a lot of pain in arm which was normal. On 10Jan2021, the patient's arm was completely swollen with hard ball underneath where the injection was given. It's extremely hot and it's extremely itchy and on an unspecified date the patient had a lot of pain in arm. She had not taken anything other than acetaminophen (TYLENOL) 650 mg. The patient thought it was due to the vaccine (COVID-19 vaccine) she got the reaction. The outcome of the events was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: I only got a mild sore shoulder with my 1st vaccination.; This is a spontaneous report from a contactable Pharmacist (patient).  A 68-year-old male patient received the 1st dose of bnt162b2 (BNT162B2, lot # EH9899) at single dose at left arm on 16Dec2020 09:00 for Covid-19 immunisation, administered at hospital.  Medical history included GOUT, environmental allergies, psoriasis, benign prostatic hyperplasia (BPH). Concomitant medication included acetaminophen (ACETAMINOPHEN), diphenhydramine (DIPHENHYDRAMINE). The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. The patient had not experienced Covid-19 prior vaccination.  The patient only got a mild sore shoulder on 17Dec2020. No treatment received. Other than that he tolerated the vaccine fine. No nausea or vomiting. Post vaccination, the patient has not been tested for COVID-19. The outcome of event was recovered.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Fatigue, Headache, Malaise, Pain
Clinical narrative: Headache for the entire day; Malaise; Fatigue; Body aches; Vivid dreams (fever); Vivid dreams (fever); This is a spontaneous report from a contactable nurse. This 41-year-old female nurse (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=Ej1685), via unspecified route at left arm on 17Dec2020 07:30 PM at single dose for COVID-19 immunization. Medical history included Insomnia and obesity. No known allergies. No other vaccine in four weeks. Concomitant medications included zolpidem tartrate (AMBIEN), acetaminophen, acetylsalicylic acid (ASPIRIN) and diphenhydramine. On 08Jan2021, patient experienced headache for the entire day, malaise and fatigue, body aches and vivid dreams (fever), all with outcome of recovered in Jan2021. No treatment was received. No COVID prior vaccination. No COVID tested post vaccination.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache for the entire day; Malaise; Fatigue; Body aches; Vivid dreams (fever); Vivid dreams (fever); This is a spontaneous report from a contactable nurse. This 41-year-old female nurse (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=Ej1685), via unspecified route at left arm on 17Dec2020 07:30 PM at single dose for COVID-19 immunization. Medical history included Insomnia and obesity. No known allergies. No other vaccine in four weeks. Concomitant medications included zolpidem tartrate (AMBIEN), acetaminophen, acetylsalicylic acid (ASPIRIN) and diphenhydramine. On 08Jan2021, patient experienced headache for the entire day, malaise and fatigue, body aches and vivid dreams (fever), all with outcome of recovered in Jan2021. No treatment was received. No COVID prior vaccination. No COVID tested post vaccination.
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Gingival bleeding, Gingival pain, Gingival swelling, Lymphadenopathy, Oral herpes
Clinical narrative: 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; This is a spontaneous report from a contactable Other HCP. This Other HCP reported for self that the 54-year-old patient of unknown gender received first dose of bnt162b2 (BNT162B2), via Intramuscular on 22Dec2020 05:00 PM on Left arm at a single dose for covid-19 immunisation. Medical history included Known allergies: Zithromax. No other vaccine in four weeks. Concomitant medication included in two weeks sertraline hydrochloride (ZOLOFT). The patient reported "48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums. I have never had any of these symptoms at any other time in my life". The events started from 24Dec2020 07:00 PM. The outcome of the events was recovered. No treatment was received. No COVID prior vaccination.  COVID tested post vaccination: covid test type post vaccination was Nasal Swab on 09Jan2021 with covid test result of Negative.  Information on the Lot/Batch Number has been requested.
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Oral mucosal blistering, Pain, SARS-CoV-2 test, Swelling
Clinical narrative: 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; 48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums.; This is a spontaneous report from a contactable Other HCP. This Other HCP reported for self that the 54-year-old patient of unknown gender received first dose of bnt162b2 (BNT162B2), via Intramuscular on 22Dec2020 05:00 PM on Left arm at a single dose for covid-19 immunisation. Medical history included Known allergies: Zithromax. No other vaccine in four weeks. Concomitant medication included in two weeks sertraline hydrochloride (ZOLOFT). The patient reported "48 hours after first dose I started with swollen sore, glands followed by a week of cold sores and blisters in my mouth. I also had swollen, painful, bleeding gums. I have never had any of these symptoms at any other time in my life". The events started from 24Dec2020 07:00 PM. The outcome of the events was recovered. No treatment was received. No COVID prior vaccination.  COVID tested post vaccination: covid test type post vaccination was Nasal Swab on 09Jan2021 with covid test result of Negative.  Information on the Lot/Batch Number has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Myalgia
Clinical narrative: chills; fever (Tmax 102.7F despite acetaminophen use); body/muscle aches; body/muscle aches; significant headache; fatigue; first dose on 16Dec2020 13:00/second dose on 05Jan2021 12:45; first dose on 16Dec2020 13:00/second dose on 05Jan2021 12:45; This is a spontaneous report from a contactable physician (patient). A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) via an unspecified route of administration at left arm on 05Jan2021 12:45 at single dose for COVID-19 immunization. Medical history included seasonal allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (lot number: EH9899) via an unspecified route of administration at left arm on 16Dec2020 13:00 at single dose for COVID-19 immunization. Approximately 9 hours following the second dose (reported as 05Jan2021 22:30) patient started with chills and fever (Tmax 102.7F despite acetaminophen use), then significant body/muscle aches, significant headache, fatigue. Symptoms lasted 24hrs from that time. Fatigue lasted 36-48hrs. Patient received home use of acetominophen, Ibuprofen, Nurtec as treatment. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was recovered in Jan2021.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use, Pain, Product use issue, Pyrexia
Clinical narrative: chills; fever (Tmax 102.7F despite acetaminophen use); body/muscle aches; body/muscle aches; significant headache; fatigue; first dose on 16Dec2020 13:00/second dose on 05Jan2021 12:45; first dose on 16Dec2020 13:00/second dose on 05Jan2021 12:45; This is a spontaneous report from a contactable physician (patient). A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) via an unspecified route of administration at left arm on 05Jan2021 12:45 at single dose for COVID-19 immunization. Medical history included seasonal allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (lot number: EH9899) via an unspecified route of administration at left arm on 16Dec2020 13:00 at single dose for COVID-19 immunization. Approximately 9 hours following the second dose (reported as 05Jan2021 22:30) patient started with chills and fever (Tmax 102.7F despite acetaminophen use), then significant body/muscle aches, significant headache, fatigue. Symptoms lasted 24hrs from that time. Fatigue lasted 36-48hrs. Patient received home use of acetominophen, Ibuprofen, Nurtec as treatment. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was recovered in Jan2021.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Myalgia, Vaccination site pain
Clinical narrative: Headache; Injections site pain; Myalgia; Malaise; This is a spontaneous report from a non-contactable physician (patient). A 27-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at left arm on 09Jan2021 16:00 at single dose for COVID-19 immunization. Medical history was reported as none and no known allergies. The patient's concomitant medications were not reported. The historical vaccine included first dose of BNT162B2 intramuscular at left arm on 19Dec2020 16:00 for COVID-19 immunization. The patient experienced headache, injections site pain, myalgia, malaise on 10Jan2021 09:00 with outcome of recovering. No treatment received for the adverse events. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19.  No follow-up attempts are possible, information about batch number cannot be obtained.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Fatigue, Nausea
Clinical narrative: Uncontrollable rigors; profound fatigue; weakness; achiness; nausea; fever (up to about 102).; This is a spontaneous report from a contactable physician reporting for himself. A 51-year-old male patient received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL3246, expiry date not reported) on 09Jan2021 at 08:30 via an unspecified route of administration in the left arm for COVID-19 immunization. The patient's medical history included penicillin allergy. No other medical history. The patient had not had COVID prior to the vaccination and had not been tested post the vaccination. The patient had received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1685, expiry date not reported) on 19Dec2020 at 16:30 via an unspecified route of administration in the left arm for COVID-19 immunization. No other vaccine received in four weeks. Concomitant medication included paracetamol (TYLENOL). On 09Jan2021 at 23:30, the patient experienced uncontrollable rigors, profound fatigue, weakness, achiness, nausea, fever (up to about 102). The events were non-serious. The patient took over the counter paracetamol (TYLENOL) and ibuprofen for the events, and was recovering from the events.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Uncontrollable rigors; profound fatigue; weakness; achiness; nausea; fever (up to about 102).; This is a spontaneous report from a contactable physician reporting for himself. A 51-year-old male patient received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL3246, expiry date not reported) on 09Jan2021 at 08:30 via an unspecified route of administration in the left arm for COVID-19 immunization. The patient's medical history included penicillin allergy. No other medical history. The patient had not had COVID prior to the vaccination and had not been tested post the vaccination. The patient had received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1685, expiry date not reported) on 19Dec2020 at 16:30 via an unspecified route of administration in the left arm for COVID-19 immunization. No other vaccine received in four weeks. Concomitant medication included paracetamol (TYLENOL). On 09Jan2021 at 23:30, the patient experienced uncontrollable rigors, profound fatigue, weakness, achiness, nausea, fever (up to about 102). The events were non-serious. The patient took over the counter paracetamol (TYLENOL) and ibuprofen for the events, and was recovering from the events.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Severe nausea/vomiting 4 days after receiving vaccine; Severe nausea/vomiting 4 days after receiving vaccine; This is a spontaneous report from a contactable other HCP reporting for herself. A 34-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 06Jan2021 at 09:15 at single dose intramuscular in left arm for COVID-19 immunisation. The patient had no relevant medical history and was not receiving concomitant medications. The patient had no known allergies.   The patient was vaccinated at hospital. Patient age at time of vaccination was 34 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient did not have COVID prior to vaccination and was not COVID tested post vaccination. The patient experienced 'severe nausea/vomiting 4 days after receiving vaccine' (as reported) with onset date on 09Jan2021 at 11:00 PM. The patient received treatment for the events with promethazine. The events resolved on an unspecified date in Jan2021.  Information on the lot/batch number has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Tachycardia
Clinical narrative: dizziness; tachycardia; This is a spontaneous report from a contactable Other HCP (patient). A 37-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EJ1685, via unspecified route of administration in the arm left on 22Dec2020 at single dose  for COVID-19 immunization. Patient medical history included pituitary gland tumor, kidney stones, binge eating disorder and unspecified allergy (known allergies: Yes). Patient was not pregnant. Concomitant medications were not reported. The patient experienced dizziness and tachycardia on 22Dec2020. No treatment was given for the events. Outcome of events was recovered on unspecified date.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache
Clinical narrative: headache; cough; This is a spontaneous report from a contactable nurse reporting for herself. A 25-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176), via an unspecified route of administration on 07Jan2021 at single dose in right arm, for COVID-19 immunisation. Age at vaccination was 25 years. The patient has known allergies to avocado and amoxicillin. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EJ1685) received on 17Dec2020. The patient did not have COVID prior to vaccination and was not COVID tested post vaccination. The patient's concomitant medications were not reported. On 08Jan2021 at 08:00 PM the patient experienced headache and cough. No treatment was received for the events. The events were resolving.